The largest database of trusted experimental protocols

13 protocols using hct116

1

Cell Culture Protocols for Cancer and Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The primary human endothelial cells, HUVECs (C2519A) and HPAECs (CC-2530), were from Lonza (Tokyo, Japan). Human pancreatic MIA PaCa-2 and colorectal HCT116 carcinoma cell lines were from the American Type Culture Collection (ATCC, Manassas, VA, USA), and the ovarian cancer RMG-1 cell line was from Japanese Health Science Research Resources Bank (Osaka, Japan). The gemcitabine-resistant human pancreatic Suit2-GR cancer cell line was a gift from Dr. Masao Tanaka (Kyushu University).49 (link) Suit2-GR and HCT116 cell lines stably expressing luciferase were established as previously reported.50 (link) HUVECs and HPAECs were cultured in EGM-2 basal media (Lonza) supplemented with the SingleQuots Kit (Lonza). HCT116 and RMG-1 cells were cultured in RPMI 1640 (Nacalai Tesque, Tokyo, Japan), and MIA PaCa-2 and Suit2-GR cells were cultured in DMEM (Nacalai Tesque), all supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Gibco, Tokyo, Japan), penicillin (100 U/mL), and streptomycin (100 μg/mL). Cells were cultured at 37°C in a humidified atmosphere equilibrated with 95% air and 5% CO2.
+ Open protocol
+ Expand
2

Cell Culture Protocols for Cancer Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human MCF-7 breast adenocarcinoma cell line was purchased from the European Collection of Cell Cultures (ECACC; Salisbury, UK). Human HL-60 promyelocytic leukemia cells, human HCT116 colorectal carcinoma cells, human A549 lung adenocarcinoma cells, the H9c2 cell line, derived from embryonic rat heart tissue, and 3T3 mouse embryo fibroblasts were obtained from the American Type Culture Collection (ATCC; Manassas, VA, USA). The MCF-7, HCT116, A549, 3T3 and H9c2 cell-types were cultured in Dulbecco’s modified Eagle’s medium (DMEM; Lonza, Basel, Switzerland). In the case of MCF-7 cells, DMEM was used without phenol red. DMEM was supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS; Lonza), 1% penicillin/streptomycin solution (Lonza) and 10 mM HEPES buffer (pH 7.0–7.6; Sigma-Aldrich). The HL-60 cell line was maintained in RPMI medium (Sigma-Aldrich) supplemented with 10% heat-inactivated FBS and 1% penicillin/streptomycin solution. All cell lines were cultured in 75 cm2 tissue culture flasks (TPP, Trasadingen, Switzerland) at 37°C in a humidified atmosphere of 5% CO2. Sub-confluent adherent cells, or the suspension of HL-60 cells, were sub-cultured every 3–4 days.
+ Open protocol
+ Expand
3

NK Cell Functional Assessment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For assessment of NK cell function, donor control PBMCs or CBMCs were plated in RPMI (Lonza, Slough, UK) containing 10% heat-inactivated fetal calf serum (FCS) supplemented with 1% penicillin and streptomycin (complete media) and containing human IL-2. Test cultures using 50% CBP diluted with complete media or complete media only contained 200 IU IL-2/well in 96-well plates. All cultures were incubated at 37°C with 5% CO2 for 48 h before PMA and ionomycin stimulation. Duplicate cultures were carried out for each experiment without PMA and ionomycin stimulation to assess levels of NKG2D and baseline CD107a. NKG2D expression on the relevant cells was determined using the unstimulated cultures and CD107a background levels in unstimulated cultures were subtracted from the values obtained for equivalent stimulated cells.
Experiments were carried out using four different, healthy PBMC donors, each tested with CBP samples from the 181 UCB units and data points represent donor means. For experiments using CBMCs, four CB units were used with seven different CBP samples. HCT116 (human colon carcinoma) used for luciferase assays were obtained from the European Collection of Cell Cultures (ECACC, Salisbury, UK). HCT116 cells were cultured in McCoy’s 5A medium (Lonza, Slough, UK) supplemented with 2 mM l-glutamine and 10% FCS at 37°C with 5% CO2.
+ Open protocol
+ Expand
4

Cultivation of Colorectal Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
A normal colorectal cell line (FHC) was purchased from the Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences (Shanghai, China), and 5 human CRC cell lines (HT29, LoVo, HCT116, SW480, and RKO) were purchased from Lonza Biologics (Hayward, CA, USA). SW480 cells were cultured in Leibovitz’s L-15 medium (Sigma, St. Louis, MO, USA; L1518), HT29 cells were cultured in MCCOYS’ 5A medium (Sigma, M9309), and FHC, HCT116, LoVo, and RKO cells were cultured in RPMI 1640 medium (Hyclone, Logan, UT, USA; SH30809.01B). All media were mixed with 10% fetal bovine serum (FBS, BI, cat. no. 04-001-1A) and antibiotics (100 units/mL penicillin and 100 mg/mL streptomycin). All cells were cultured at 37 °C in a humidified atmosphere containing 5% CO2.
+ Open protocol
+ Expand
5

Detecting Colon Cancer Cells by CK20 and Survivin

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sensitivity and specificity of CK20 and survivin expression for CTC detection were investigated using whole blood from healthy controls and human colon cancer cell lines: HT29, SW480, HCT116 and Caco2. All cell lines were purchased from American Type Culture Connection (ATCC, Lockville, MD) in 2007 (HCT116) and 2011(HT29, SW480 and Caco2) (no authentication was done by the authors). HT29, SW480, HCT116 and Caco2 cell lines were maintained in McCoy's 5A and DMEM media, respectively, and supplemented with 10% fetal bovine serum (Lonza, East Rutherford, NJ), 5% penicillin/streptomycin, sodium pyruvate and L-Glutamine (Mediatech, Inc. Manassas, VA). We tested whether CK20 and surviving could be detected from live-captured cancer cells by spiking normal blood with HT29, SW480, HCT116 and Caco2 cancer cells. After using trypsin to dissociate the cells, the number of colon cancer cells was counted three times and their mean was determined. Predetermined numbers of cells (10, 100, and 1000) were spiked in 8 ml peripheral blood samples from healthy controls to test our enrichment method with Dynabeads. After mRNA isolation, CK20 and surviving expression were analyzed by RT-PCR and q-RT-PCR.
+ Open protocol
+ Expand
6

Lung Cancer Cell Line Culturing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human lung cancer-derived cell lines, A549, NCI-H322, H358, H1299, H146, H596, H82, H526, H417, H446, H727, H292, H1155, H157, and H1688 cells were obtained from Curt Harris (NCI), H838 and H1703 cells were from Giuseppe Giaccone (then NCI, currently Georgetown University), and SW620 colon cancer derived cell line was from the DTP (Developmental Therapeutics Program, NCI/DCTD (Division of Cancer Treatments and Diagnostics)) tumor cell lines depository. HeLa and HCT116 cells were purchased from American Type Culture Collection (ATCC).
Most of human cell lines were cultured in RPMI 1640 Medium (LONZA) with or without heat-inactivated fetal bovine serum (FBS: GEMINI BIO), supplemented with penicillin/streptomycin (1:100) or antibiotic/antimycotic solution (10,000 units/ml penicillin G, 10 mg/ml streptomycin sulfate, 25 μg/ml amphotericin B: GEMINI BIO) at 37 ˚C, 5% CO2. HCT116 cells were cultured in McCoy’s 5A Medium (LONZA) instead of RPMI1640 as a medium. For in vitro CCK8 assays, rhSCGB3A2 (1 μg/ml) containing 0.00936 EU (endotoxin unit)/μg of LPS17 (link) was mixed with 100 pg/ml of LPS (10:1 weight ratio for rhSCGB3A2/LPS) and incubated for 10 min at room temperature prior to addition to the culture media.
+ Open protocol
+ Expand
7

Culturing and Validating Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human cell lines PC-3 (prostate adenocarcinoma), DU145 (prostate adenocarcinoma), SiHa (cervical squamous cell carcinoma), A375 (melanoma), and HCT-116 (colon adenocarcinoma) were purchased from and authenticated by the American Type Culture Collection (ATCC) and cultured in appropriate media supplemented with 10% fetal bovine serum (Lonza) and 50 mg/L gentamicin sulfate (Lonza). The identity of each cell line was confirmed using Identifiler STR genotyping (Applied Biosystems). Cells were cultured for less than 6 months before renewal from early passage, frozen stocks. Cells were maintained at 37°C in a humidified incubator containing 21% O2 and 5% CO2 in air (referred to as normoxic conditions). For hypoxic culture, PC-3 cells were placed in a CO2 incubator flushed with a mixture of gas containing 1% O2, 5% CO2, and 94% N2 for 24 hours (details in Supplemental Methods). Cells were grown to super-confluence in T75 (75 cm2) flasks, washed in cold phosphate-buffered saline (PBS), and immediately lysed in the flask on ice. To increase baseline HIF-1α levels prior to lysis, SiHa cells were treated with 1 µM bortezomib (Fisher Scientific) for 4 hours.
+ Open protocol
+ Expand
8

Culturing Human Cell Lines for Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical
vein endothelial primary cells (HUVECs) and human colorectal carcinoma
cell lines (HCT116) were purchased from Lonza and the American Type
Culture Collection (ATCC), respectively. HUVECs were cultured in EBM-2
Basal Medium (Lonza), supplied with Microvascular Endothelial Cell
Growth Medium SingleQuots supplements (EGM-2 MV, Lonza) and 1% Antibiotic-Antimycotic
(Gibco). HUVECs from passages 3–8 were used in the experiments.
The HCT116 were cultured in Dulbecco’s modified eagle medium
(DMEM, Gibco), supplied with 10% fetal bovine serum (FBS, Gibco) and
1% penicillin-streptomycin (Bio-Techne Corporation). The T cells were
obtained from the Human Immunology Core of Penn Medicine and maintained
in RPMI-1640 (ATCC), supplied with 10% FBS, 1% Pen-Strep, and 10 ng/mL
Recombinant Human IL-2 (Biolegend). All of the cells were maintained
regularly with medium change each other day. For HUVECs and HCT116,
0.05% Trypsin-EDTA (Bio-Techne Corp.) was employed for the passaging.
+ Open protocol
+ Expand
9

CTNNB1 Mutational Status in Colorectal Cancer Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Colorectal cancer cell lines DLD1 were purchased from Horizon, HCT116 and LS180 from ATCC. The reported mutational status of CTNNB1 (wt/wt for DLD1, del45S/wt for HCT116, and S45F/S45F for LS180) (https://www.ncbi.nlm.nih.gov/pubmed/24755471) was confirmed by DNA Sanger sequencing. DLD1, HCT116, and LS180 cells were cultured in RPMI medium, DMEM supplemented with 2 mM Ultraglutamine (Lonza), or EMEM, respectively, each containing 10% FCS and 100 U/ml penicillin-streptomycin (Biochrom).
+ Open protocol
+ Expand
10

Culturing Colorectal Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human HCT-116, HT-29, Caco-2, and SW48 colorectal cancer cell lines were obtained from the American Type Culture Collection (ATCC) (Manassas, VA, USA). The human GEO colon cancer cell was a gift of Dr. N. Normanno (National Cancer Institute, Naples, Italy). The HCT-116 and HT-29 cancer cells were cultured in RPMI 1640 medium (Lonza, Cologne, Germany), and supplemented with 10% FBS, 2 mM L-glutamine, 50 U/mL penicillin, and 100 µg/mL streptomycin (Lonza, Cologne, Germany). Caco-2 cell line was cultured in DMEM medium (Lonza, Cologne, Germany), and supplemented with 10% FBS, 2 mM L-glutamine, 1% non-essential amino acid, 50 U/mL penicillin, and 100 µg/mL streptomycin (Lonza, Cologne, Germany). The GEO and GEO-CR clones were grown on DMEM medium supplemented with 20% FBS, 1% penicillin/streptomycin (Lonza, Cologne, Germany). The SW48 and SW48-CR cells were cultured in RPMI 1640 medium supplemented with 10% FBS and 1% penicillin/streptomycin. All cell lines were maintained in a humified atmosphere of 95% air and 5% CO2 at 37 °C, and routinely screened for the presence of mycoplasma (Mycoplasma Detection Kit, Roche Diagnostics, Basel, Switzerland).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!